Unknown

Dataset Information

0

Combination of Gold Nanoparticle-Conjugated Tumor Necrosis Factor-? and Radiation Therapy Results in a Synergistic Antitumor Response in Murine Carcinoma Models.


ABSTRACT: Although remarkable preclinical antitumor effects have been shown for tumor necrosis factor-? (TNF) alone and combined with radiation, its clinical use has been hindered by systemic dose-limiting toxicities. We investigated the physiological and antitumor effects of radiation therapy combined with the novel nanomedicine CYT-6091, a 27-nm average-diameter polyethylene glycol-TNF-coated gold nanoparticle, which recently passed through phase 1 trials.The physiologic and antitumor effects of single and fractionated radiation combined with CYT-6091 were studied in the murine 4T1 breast carcinoma and SCCVII head and neck tumor squamous cell carcinoma models.In the 4T1 murine breast tumor model, we observed a significant reduction in the tumor interstitial fluid pressure (IFP) 24 hours after CYT-6091 alone and combined with a radiation dose of 12 Gy (P<.05 vs control). In contrast, radiation alone (12 Gy) had a negligible effect on the IFP. In the SCCVII head and neck tumor model, the baseline IFP was not markedly elevated, and little additional change occurred in the IFP after single-dose radiation or combined therapy (P>.05 vs control) despite extensive vascular damage observed. The IFP reduction in the 4T1 model was also associated with marked vascular damage and extravasation of red blood cells into the tumor interstitium. A sustained reduction in tumor cell density was observed in the combined therapy group compared with all other groups (P<.05). Finally, we observed a more than twofold delay in tumor growth when CYT-6091 was combined with a single 20-Gy radiation dose-notably, irrespective of the treatment sequence. Moreover, when hypofractionated radiation (12 Gy × 3) was applied with CYT-6091 treatment, a more than five-fold growth delay was observed in the combined treatment group of both tumor models and determined to be synergistic.Our results have demonstrated that TNF-labeled gold nanoparticles combined with single or fractionated high-dose radiation therapy is effective in reducing IFP and tumor growth and shows promise for clinical translation.

SUBMITTER: Koonce NA 

PROVIDER: S-EPMC4934370 | biostudies-literature | 2015 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Combination of Gold Nanoparticle-Conjugated Tumor Necrosis Factor-α and Radiation Therapy Results in a Synergistic Antitumor Response in Murine Carcinoma Models.

Koonce Nathan A NA   Quick Charles M CM   Hardee Matthew E ME   Jamshidi-Parsian Azemat A   Dent Judith A JA   Paciotti Giulio F GF   Nedosekin Dmitry D   Dings Ruud P M RP   Griffin Robert J RJ  

International journal of radiation oncology, biology, physics 20150726 3


<h4>Purpose</h4>Although remarkable preclinical antitumor effects have been shown for tumor necrosis factor-α (TNF) alone and combined with radiation, its clinical use has been hindered by systemic dose-limiting toxicities. We investigated the physiological and antitumor effects of radiation therapy combined with the novel nanomedicine CYT-6091, a 27-nm average-diameter polyethylene glycol-TNF-coated gold nanoparticle, which recently passed through phase 1 trials.<h4>Methods and materials</h4>Th  ...[more]

Similar Datasets

| S-EPMC6300922 | biostudies-literature
| S-EPMC4101987 | biostudies-literature
| S-EPMC6764416 | biostudies-literature
| S-EPMC8933417 | biostudies-literature
| S-EPMC3534156 | biostudies-literature
| S-EPMC6474148 | biostudies-literature
| S-EPMC9798857 | biostudies-literature
| S-EPMC6364920 | biostudies-literature
| S-EPMC7455757 | biostudies-literature
| S-EPMC5684491 | biostudies-literature